Proton pump inhibitors and hyporesponsiveness to erythropoiesis stimulating agents in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study

Conclusions This study showed the associations between PPI and ERI, ESA dose, and TSAT in hemodialysis patients; physicians should consider anemia's associations with PPIs in hemodialysis patients.PMID:37935135 | DOI:10.1159/000534701
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Source Type: research